Relates to prescription labels for mifepristone and misoprostol
Summary
Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2025
Committee Review
Mar 2025
Assembly Passage
Mar 2025
Senate Passage
Mar 2025
Signed into Law
Mar 2025
Introduced Feb 12, 2025
Signed Mar 20, 2025
Floor votes · Senate Mar 10, 2025 · Assembly Mar 5, 2025
How they voted
40–21
Passed · 2 other
Total votes 63
Mar 10, 2025
D
Democratic41
95% Yea
R
Republican22
90% Nay
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
14
Key actions
3
Committee
3
Mar 20, 2025
Signed into law
SIGNED CHAP.108
lower
Mar 10, 2025
Upper · Passed
PASSED SENATE
upper
Mar 5, 2025
Committee
REFERRED TO RULES
upper
Mar 5, 2025
Lower · Passed
PASSED ASSEMBLY
lower
Feb 24, 2025
Committee
REPORTED REFERRED TO RULES
lower
Feb 12, 2025
Committee
REFERRED TO HIGHER EDUCATION
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Karines Reyes
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 5285
Scope: NY
Hi! I can help you understand A 5285. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline